{"title": "Clinical Characteristics on 25 Discharged Patients with COVID-19 Virus Returning", "doi": "10.1101/2020.03.06.20031377", "citation_id": "2020.03.06.20031377v1", "date": "2020-03-10", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.06.20031377", "abstract": "<p>Here we report the clinical features of 25 discharged patients with COVID-19 recovery. Our analysis indicated that there\nwas a significant inverse correlation existed between serum D-Dimer level and the duration of antiviral treatment, while\nlymphocyte concentration significantly positively correlated with the duration of virus reversal.</p>", "twitter_description": "Here we report the clinical features of 25 discharged patients with COVID-19 recovery. Our analysis indicated that there was a significant inverse correlation existed between serum D-Dimer level and the duration of antiviral treatment, while lymphocyte concentration significantly positively correlated with the duration of virus reversal.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThis work was supported by Sanming Project of Medicine in Shenzhen (SZSM201512005).\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nAnyone who wishes to share, reuse, remix, or adapt this material please send email to the corresponding author.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.06.20031377v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.06.20031377v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.06.20031377v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/10/2020.03.06.20031377.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.06.20031377v1", "access_rights": "restricted", "authors": ["Jing Yuan", "Shanglong Kou", "Yanhua Liang", "Jianfeng Zeng", "Yanchao Pan", "Lei Liu"]}